| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $224K | +137.1% | +24.6% |
| Cost of Revenue | $171K | +123.3% | +47.8% |
| Gross Profit | $53K | +195.7% | -17.1% |
| R&D Expense | $74K | +9278.7% | -45.6% |
| SG&A Expense | $282K | +75.1% | +127.9% |
| Operating Income | -$675K | +31.2% | +67.2% |
| Interest Expense | $243K | +35.3% | +142.8% |
| Net Income | -$918K | +26.2% | +73.2% |
| EPS (Diluted) | -$0.01 | -200.0% | +66.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $118K | +213.6% | +42.1% |
| Inventory | $1.7M | +41.1% | +1914.9% |
| Current Assets | $2.0M | -10.8% | -20.8% |
| Total Assets | $3.3M | -7.9% | +24.0% |
| Current Liabilities | $12.0M | +6.3% | +70.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | — |
| Capital Expenditures | $281K | — | — |
| Investing Cash Flow | -$281K | — | — |
| Financing Cash Flow | $1.7M | — | — |
| Free Cash Flow | -$2.7M | — | — |
| $12.7M |
| +5.1% |
| +63.9% |
| Stockholders' Equity | -$9.3M | -10.6% | -85.2% |